Showing 281 - 300 results of 144,430 for search '(( 1 b decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 2.07s Refine Results
  1. 281

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…F-53B also induced Parkinson’s disease (PD)-like disorders including dyskinesia (incidence: 22.8–27.9%), dopaminergic neuronal damage (neuritic blebbings and broken neurites) and decreased dopamine levels (15.2–28.1%), increased abundance (1.3–1.4 fold) and aggregation of α-synuclein. …”
  2. 282

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…F-53B also induced Parkinson’s disease (PD)-like disorders including dyskinesia (incidence: 22.8–27.9%), dopaminergic neuronal damage (neuritic blebbings and broken neurites) and decreased dopamine levels (15.2–28.1%), increased abundance (1.3–1.4 fold) and aggregation of α-synuclein. …”
  3. 283

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…F-53B also induced Parkinson’s disease (PD)-like disorders including dyskinesia (incidence: 22.8–27.9%), dopaminergic neuronal damage (neuritic blebbings and broken neurites) and decreased dopamine levels (15.2–28.1%), increased abundance (1.3–1.4 fold) and aggregation of α-synuclein. …”
  4. 284

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…F-53B also induced Parkinson’s disease (PD)-like disorders including dyskinesia (incidence: 22.8–27.9%), dopaminergic neuronal damage (neuritic blebbings and broken neurites) and decreased dopamine levels (15.2–28.1%), increased abundance (1.3–1.4 fold) and aggregation of α-synuclein. …”
  5. 285
  6. 286
  7. 287
  8. 288

    MMR mutants show decreased mating-type silencing. by Qian Liu (135614)

    Published 2020
    “…<b>(D)</b> Cells of indicated strains were 10-fold serially diluted and then spotted onto SC (left), SD-Ura (middle) and SC+FOA(right) agar plates, the <i>sir1Δ</i> mutant served as a positive control. …”
  9. 289
  10. 290
  11. 291

    GSK343 decreased neuroblastoma viability, proliferation, and motility. by Laura V. Bownes (10276762)

    Published 2021
    “…<p>(A) SK-N-AS, SK-N-BE(2), SH-EP and WAC(2) cells (1.5 × 10<sup>3</sup> cells) were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and viability was measured using alamarBlue<sup>®</sup> assay. …”
  12. 292
  13. 293
  14. 294
  15. 295

    Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

    Published 2014
    “…The corresponding cross section height measurements show a height decrease by slightly less than 100 nm (from ∼10 nm to −100 nm in the encircled area; lower panel); the arrow in the AFM images points to an intact intercellular connection before cutting (<b>E1</b>) and the disappearance thereof after cutting (<b>E2</b>). …”
  16. 296
  17. 297
  18. 298
  19. 299
  20. 300